"RSV Vaccine Approved: A Look at Top Vaccines and Their Effectiveness"

The FDA and CDC have approved the first RSV vaccines for infants and seniors, with other RSV vaccines expected to be approved by the fall. RSV is a common respiratory infection that can lead to serious lung infections, particularly in children, older adults, and those with underlying health conditions. Pfizer, GSK, Johnson & Johnson, and Moderna have all developed RSV vaccines that have shown promising results in trials. The vaccines have been found to be effective in reducing the risk of severe illness and symptomatic illness in older adults, as well as protecting infants from severe infections. Sanofi and AstraZeneca have also developed monoclonal antibody injections for infants, which have shown high protection rates against severe illness. RSV vaccines are expected to be available this fall when RSV cases are predicted to rise.